Clinical Trial: Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma
Brief Summary: To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.
Detailed Summary: The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.
Sponsor: Kansai Hepatobiliary Oncology Group
Current Primary Outcome:
- 3-year recurrence-free survival rate [ Time Frame: 11 years (2000-2010) ]
- Ratio of local recurrence at the hepatico-duodenal ligament [ Time Frame: 11 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Kansai Hepatobiliary Oncology Group
Dates:
Date Received: May 14, 2013
Date Started: March 2013
Date Completion:
Last Updated: June 29, 2014
Last Verified: June 2014
